Literature DB >> 17828290

Alpha-4/beta-1 and alpha-L/beta-2 integrins mediate cytokine induced lung leukocyte-epithelial adhesion and injury.

L A Parmley1, N D Elkins, M A Fini, Y-E Liu, J E Repine, R M Wright.   

Abstract

BACKGROUND AND
PURPOSE: Injury to the alveolar epithelium is a critical feature of acute lung injury (ALI). Using a cytokine model of ALI we demonstrated previously that newly recruited mononuclear phagocytes (MNP) contributed to lung inflammation and injury. We hypothesized that cytokines delivered into the alveolar airspace would have multiple effects on the lung that may contribute to lung injury. EXPERIMENTAL APPROACH: Intratracheal cytokine insufflation and leukocyte adoptive transfer in vivo were combined with in vitro analyses of lung epithelial cell-MNP adhesion and injury. Lung inflammatory injury was assessed by histology, leukocyte infiltration, and release of LDH and RAGE. KEY
RESULTS: Cytokine insufflation was associated with apparent MNP-epithelial adhesion, up-regulation of alveolar ICAM-1 and VCAM-1, and the release of LDH and RAGE into the bronchoalveolar lavage. Insufflation of small molecule integrin antagonists suppressed adhesion of MNP and modulated release of LDH and RAGE. Adoptive transfer of MNP purified from cytokine insufflated lungs into leukopenic rats demonstrated the requirement of MNP for release of LDH that was not induced by cytokine alone. Corroboration that disrupting the ICAM/LFA1 interaction or the VCAM/VLA4 interaction blocked MNP-epithelial cell interaction and injury was obtained in vitro using both blocking monoclonal antibodies and the small molecule integrin antagonists, BIO5192 and XVA143. CONCLUSIONS AND IMPLICATIONS: MNP recruited following cytokine insufflation contributed to lung injury. Further, integrin antagonists reduced alveolar epithelial cell injury induced during lung inflammation. Intratracheal delivery of small molecule antagonsists of leukocyte-epithelial adhesion that prevent lung injury may have significant clinical utility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828290      PMCID: PMC2078224          DOI: 10.1038/sj.bjp.0707443

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  77 in total

Review 1.  Airways inflammation and COPD: epithelial-neutrophil interactions.

Authors:  Carol A Pettersen; Kenneth B Adler
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

Review 2.  Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Authors:  Marina A Dobrovolskaia; Stefanie N Vogel
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

3.  Interferon-gamma-induced epithelial ICAM-1 expression and monocyte adhesion. Involvement of protein kinase C-dependent c-Src tyrosine kinase activation pathway.

Authors:  Ya-Jen Chang; Michael J Holtzman; Ching-Chow Chen
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

4.  Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice.

Authors:  Ulrich A Maus; M Audrey Koay; Tim Delbeck; Matthias Mack; Monika Ermert; Leander Ermert; Timothy S Blackwell; John W Christman; Detlef Schlöndorff; Werner Seeger; Jürgen Lohmeyer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-06       Impact factor: 5.464

5.  Hypoxia mediates increased neutrophil and macrophage adhesiveness to alveolar epithelial cells.

Authors:  B Beck-Schimmer; R C Schimmer; C Madjdpour; J M Bonvini; T Pasch; P A Ward
Journal:  Am J Respir Cell Mol Biol       Date:  2001-12       Impact factor: 6.914

6.  Small molecule inhibitors induce conformational changes in the I domain and the I-like domain of lymphocyte function-associated antigen-1. Molecular insights into integrin inhibition.

Authors:  Karl Welzenbach; Ulrich Hommel; Gabriele Weitz-Schmidt
Journal:  J Biol Chem       Date:  2002-01-07       Impact factor: 5.157

7.  Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation.

Authors:  B Beck-Schimmer; C Madjdpour; S Kneller; U Ziegler; T Pasch; R P Wüthrich; P A Ward; R C Schimmer
Journal:  Eur Respir J       Date:  2002-06       Impact factor: 16.671

8.  Autocrine production of IFN-gamma by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice.

Authors:  Carla E Carvalho-Pinto; María I García; Mario Mellado; J Miguel Rodríguez-Frade; Juan Martín-Caballero; Juana Flores; Carlos Martínez-A; Dimitrios Balomenos
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

9.  ICAM-1 facilitates alveolar macrophage phagocytic activity through effects on migration over the AEC surface.

Authors:  Robert Paine; Susan B Morris; Hong Jin; Carlos E O Baleeiro; Steven E Wilcoxen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-07       Impact factor: 5.464

10.  Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase.

Authors:  S Ehrt; D Schnappinger; S Bekiranov; J Drenkow; S Shi; T R Gingeras; T Gaasterland; G Schoolnik; C Nathan
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  7 in total

1.  Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}.

Authors:  Sophie Gibbings; Nancy D Elkins; Hillary Fitzgerald; Janice Tiao; Mari E Weyman; Gayle Shibao; Mehdi A Fini; Richard M Wright
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

2.  DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs.

Authors:  Samantha Deianira Dattoli; Monica Baiula; Rossella De Marco; Andrea Bedini; Michele Anselmi; Luca Gentilucci; Santi Spampinato
Journal:  Br J Pharmacol       Date:  2018-09-17       Impact factor: 8.739

3.  IGSF3 mutation identified in patient with severe COPD alters cell function and motility.

Authors:  Kelly S Schweitzer; Natini Jinawath; Raluca Yonescu; Kevin Ni; Natalia Rush; Varodom Charoensawan; Irina Bronova; Evgeny Berdyshev; Sonia M Leach; Lucas A Gillenwater; Russel P Bowler; David B Pearse; Constance A Griffin; Irina Petrache
Journal:  JCI Insight       Date:  2020-07-23

4.  A Critical Role for P2X7 Receptor-Induced VCAM-1 Shedding and Neutrophil Infiltration during Acute Lung Injury.

Authors:  Amarjit Mishra; Yujie Guo; Li Zhang; Sunil More; Tingting Weng; Narendranath Reddy Chintagari; Chaoqun Huang; Yurong Liang; Samuel Pushparaj; Deming Gou; Melanie Breshears; Lin Liu
Journal:  J Immunol       Date:  2016-08-24       Impact factor: 5.422

Review 5.  The receptor for advanced glycation end products (RAGE) and the lung.

Authors:  Stephen T Buckley; Carsten Ehrhardt
Journal:  J Biomed Biotechnol       Date:  2010-01-19

Review 6.  Treatment of allergic asthma: modulation of Th2 cells and their responses.

Authors:  Berislav Bosnjak; Barbara Stelzmueller; Klaus J Erb; Michelle M Epstein
Journal:  Respir Res       Date:  2011-08-25

Review 7.  Receptor for advanced glycation end products and its involvement in inflammatory diseases.

Authors:  Yaw Kuang Chuah; Rusliza Basir; Herni Talib; Tung Hing Tie; Norshariza Nordin
Journal:  Int J Inflam       Date:  2013-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.